TY - JOUR
T1 - The economic burden of chronic diseases
T2 - Estimates and projections for China, Japan, and South Korea
AU - Bloom, David E.
AU - Chen, Simiao
AU - Kuhn, Michael
AU - McGovern, Mark E.
AU - Oxley, Les
AU - Prettner, Klaus
N1 - Funding Information:
Research reported in this paper was supported by the National Institute on Aging, National Institutes of Health, under award numbers P30AG024409 and R01AG048037 and by a grant from Carnegie Corporation of New York. The statements made and views expressed are solely the responsibility of the authors.
Publisher Copyright:
© 2018
PY - 2020/10
Y1 - 2020/10
N2 - We propose a novel framework to analyze the macroeconomic impact of non-communicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic burden of chronic health conditions in terms of foregone gross domestic product (GDP). Unlike earlier frameworks, this approach allows us to account for i) variations in human capital for workers in different age groups, ii) mortality and morbidity effects of non-communicable diseases, and iii) the treatment costs of diseases. We apply our methodology to China, Japan, and South Korea, and estimate the economic burden of chronic conditions in five domains (cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, and mental health conditions). Overall, total losses associated with these diseases over the period 2010–2030 are (measured in real USD with the base year 2010) estimated to be $7.7 trillion for China, $3.5 trillion for Japan, and $1 trillion for South Korea.
AB - We propose a novel framework to analyze the macroeconomic impact of non-communicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic burden of chronic health conditions in terms of foregone gross domestic product (GDP). Unlike earlier frameworks, this approach allows us to account for i) variations in human capital for workers in different age groups, ii) mortality and morbidity effects of non-communicable diseases, and iii) the treatment costs of diseases. We apply our methodology to China, Japan, and South Korea, and estimate the economic burden of chronic conditions in five domains (cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, and mental health conditions). Overall, total losses associated with these diseases over the period 2010–2030 are (measured in real USD with the base year 2010) estimated to be $7.7 trillion for China, $3.5 trillion for Japan, and $1 trillion for South Korea.
KW - Ageing
KW - Aggregate output
KW - East Asia
KW - Economic burden of disease
KW - Health
KW - Human capital
KW - Non-communicable diseases
UR - http://www.scopus.com/inward/record.url?scp=85059562581&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059562581&partnerID=8YFLogxK
U2 - 10.1016/j.jeoa.2018.09.002
DO - 10.1016/j.jeoa.2018.09.002
M3 - Article
AN - SCOPUS:85059562581
SN - 2212-828X
VL - 17
JO - Journal of the Economics of Ageing
JF - Journal of the Economics of Ageing
M1 - 100163
ER -